Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT01135225
First received: May 31, 2010
Last updated: January 29, 2015
Last verified: January 2015